TATE Versus TACE, an Open-label Randomized Study Comparing TransArterial Tirapazamine Embolization Versus TransArterial ChemoEmbolization in Intermediate Stage Hepatocellular Carcinoma
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Tirapazamine (Primary) ; Doxorubicin; Ethiodized oil
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Teclison
- 13 Nov 2017 Planned number of patients changed from 114 to 134.
- 13 Nov 2017 Status changed from not yet recruiting to recruiting.
- 11 May 2017 New trial record